These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22413793)

  • 1. Challenges associated with the demonstration of bioequivalence of intramammary products in ruminants.
    Lainesse C; Gehring R; Pasloske K; Smith G; Soback S; Wagner S; Whittem T
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():65-79. PubMed ID: 22413793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for extrapolating in vivo bioequivalence data across species and routes.
    Modric S; Bermingham E; Heit M; Lainesse C; Thompson C
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():45-52. PubMed ID: 22413791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current challenges facing the determination of product bioequivalence in veterinary medicine.
    Martinez MN; Hunter RP
    J Vet Pharmacol Ther; 2010 Oct; 33(5):418-33. PubMed ID: 20840385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges obtaining a biowaiver for topical veterinary dosage forms.
    Baynes R; Riviere J; Franz T; Monteiro-Riviere N; Lehman P; Peyrou M; Toutain PL
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():103-14. PubMed ID: 22413798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstrating bioequivalence using clinical endpoint studies.
    Bermingham E; Del Castillo JR; Lainesse C; Pasloske K; Radecki S
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():31-7. PubMed ID: 22413789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis.
    Gehring R; Smith GW
    J Vet Pharmacol Ther; 2006 Aug; 29(4):237-41. PubMed ID: 16846460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing bioequivalence of veterinary premixes (Type A medicated articles).
    Hunter RP; Lees P; Concordet D; Toutain PL
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():53-63. PubMed ID: 22413792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating product bioequivalence for highly variable veterinary drugs.
    Claxton R; Cook J; Endrenyi L; Lucas A; Martinez MN; Sutton SC
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():11-6. PubMed ID: 22413787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug solubility classification in the bovine.
    Martinez MN; Apley MD
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():93-7. PubMed ID: 22413796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination.
    Lees P; Hunter RP; Reeves PT; Toutain PL
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():17-29. PubMed ID: 22413788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Article IV: clinical application of pharmacokinetics.
    Martinez MN
    J Am Vet Med Assoc; 1998 Nov; 213(10):1418-20. PubMed ID: 9828932
    [No Abstract]   [Full Text] [Related]  

  • 12. Milk and plasma disposition of thymol following intramammary administration of a phytoceutical mastitis treatment.
    McPhee CS; Anderson KL; Yeatts JL; Mason SE; Barlow BM; Baynes RE
    J Dairy Sci; 2011 Apr; 94(4):1738-43. PubMed ID: 21426962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence accomplishments, ongoing initiatives, and remaining challenges.
    Martinez MN
    J Vet Pharmacol Ther; 2014 Feb; 37(1):2-12. PubMed ID: 23841644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of systemic or intramammary antimicrobial treatment of bovine subclinical mastitis during lactation.
    Sandgren CH; Waller KP; Emanuelson U
    Vet J; 2008 Jan; 175(1):108-17. PubMed ID: 17320434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of subclinical mastitis in early lactation in dairy goats.
    McDougall S; Supré K; De Vliegher S; Haesebrouck F; Hussein H; Clausen L; Prosser C
    J Dairy Sci; 2010 Oct; 93(10):4710-21. PubMed ID: 20855005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Special series--use of pharmacokinetics in veterinary medicine. Article III: Physicochemical properties of pharmaceuticals.
    Martinez MN
    J Am Vet Med Assoc; 1998 Nov; 213(9):1274-7. PubMed ID: 9810382
    [No Abstract]   [Full Text] [Related]  

  • 19. Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation.
    Pinzón-Sánchez C; Cabrera VE; Ruegg PL
    J Dairy Sci; 2011 Apr; 94(4):1873-92. PubMed ID: 21426977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of oxidative stress in ruminant medicine.
    Celi P
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):233-40. PubMed ID: 20849293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.